Pharmaceutical Preparations · DE · CIK 1819576
Liquidia Corp develops and commercializes treatments for challenging respiratory and vascular diseases like pulmonary arterial hypertension
Comparable business profile · signals at a glance
In the 90 days to Mar 27, 2026: 10 sold $16.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | Bloch Stephen MDirector | Sell | 30,176 | $36.38 | $1.1M |
| Mar 27, 2026 | Bloch Stephen MDirector | Sell | 30,401 | $35.42 | $1.1M |
| Mar 27, 2026 | Bloch Stephen MDirector | Sell | 1,973 | $37.13 | $73K |
| Mar 26, 2026 | Bloch Stephen MDirector | Sell | 7,684 | $37.22 | $286K |
| Mar 23, 2026 | Moomaw ScottChief Commercial Officer | Sell | 17,000 | $36.81 | $626K |
| Mar 23, 2026 | Moomaw ScottChief Commercial Officer | Sell | 1,314 | $36.48 | $48K |
| Mar 13, 2026 | Saggar RajeevChief Medical Officer | Sell | 35,365 | $36.30 | $1.3M |
| Mar 13, 2026 | Singh RamanDirector | Sell | 20,000 | $36.04 | $721K |
| Mar 13, 2026 | Krepp SarahChief Human Resource Officer | Sell | 16,261 | $38.00 | $618K |
| Mar 9, 2026 | Moomaw ScottChief Commercial Officer | Sell | 80,000 | $35.32 | $2.8M |
| Mar 2, 2026 | Kaseta MichaelCFO and COO | Sell | 1,165 | $30.58 | $36K |
| Mar 2, 2026 | Schundler RussellGeneral Counsel | Sell | 1,073 | $30.58 | $33K |
| Mar 2, 2026 | Moomaw ScottChief Commercial Officer | Sell | 827 | $30.58 | $25K |
| Mar 2, 2026 | Adair JasonChief Business Officer | Sell | 689 | $30.58 | $21K |
| Mar 2, 2026 | Boyle DanaChief Accounting Officer | Sell | 445 | $30.58 | $14K |
| Mar 2, 2026 | Krepp SarahChief Human Resource Officer | Sell | 276 | $30.58 | $8K |
| Jan 26, 2026 | Boyle DanaChief Accounting Officer | Sell | 1,580 | $41.65 | $66K |
| Jan 26, 2026 | Adair JasonChief Business Officer | Sell | 688 | $41.65 | $29K |
| Jan 12, 2026 | Jeffs RogerChief Executive Officer | Sell | 66,610 | $37.43 | $2.5M |
| Jan 12, 2026 | Kaseta MichaelCFO and COO | Sell | 36,932 | $37.43 | $1.4M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.